SCHEMBL5083177

SCHEMBL5083177

CC(c1ccc(F)cc1)C(CCN1CCCCC1)CSc1nc2ccccc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.46
DRD4 P21917 2/20 0.46
HTR2A P28223 2/20 0.46
HTR7 P34969 2/20 0.46
DRD3 P35462 2/20 0.46
ALDH1A1 P00352 4/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SOAT1 P35610 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026258 0.71 DRD2 (0.54) DRD2DRD4HTR2AHTR7DRD3
SCHEMBL10431044 0.71 ACHE (0.50) LMNANPSR1
SCHEMBL7327983 0.71 DRD2 (0.56) DRD2DRD4HTR2AHTR7DRD3
SCHEMBL28159149 0.69 CYP1A2 (0.51) DRD2HTR2AHTR7DRD3ALDH1A1
SCHEMBL28159148 0.69 POLB (0.54) ALDH1A1HPGDNPC1MAPTRAB9A
SCHEMBL10989220 0.68 CYP1A2 (0.67) DRD2HTR2AHTR7DRD3ALDH1A1
SCHEMBL9560694 0.68 LTA4H (0.43) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL7414312 0.66 PSEN1 (0.41)
SCHEMBL29023739 0.66 APEX1 (0.61) DRD2HTR2AHTR7DRD3ALDH1A1
SCHEMBL27777618 0.66 ALDH1A1 (0.56) ALDH1A1HPGDNPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed